Revolutionary Peanut Allergy Treatment Is One Step Closer
DBV Tech shares shot up on Thursday after the company announced the submission of paperwork to the FDA for Viaskin Peanut for the treatment of peanut-allergic children.
DBV Tech shares shot up on Thursday after the company announced the submission of paperwork to the FDA for Viaskin Peanut for the treatment of peanut-allergic children.
Rhythm Pharma shares jumped on Wednesday after the company announced positive results from two of its late-stage obesity clinical trials.
Insulet shares surged after it reported earnings. The company's Omnipod insulin management system saw stellar growth in sales.
Minerva Neurosciences shares jumped on Monday after the company announced positive topline results from its two mid-stage studies in major depressive disorder (MDD) and insomnia. Specifically, these were two Phase 2b studies of seltorexant.
One primary reason that longevity in the United States has grown for decades is more effective treatments for cardiovascular disease. The period of progress may have ended though, according to a new study.
GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction with Pfizer.
As many as a million Californians can’t drink the water that comes out of their tap. Most people have heard about the ongoing water crisis in Flint, Michigan, where civic cost-cutting measures resulted in…
Vitamin D is known as “the sunshine vitamin” because sunlight spurs its creation in the body. A new study suggests that one of its counterparts, vitamin A, might be the anti-sunshine vitamin — in…
In a new survey of 21 major cities conducted by Sleep Junkie, an online bedding merchant, the City of Brotherly Love was found to also be the City of Sleepness Nights. Only 40% of…
Amgen shares rose early Wednesday after it released better than expected second-quarter financial results late on Tuesday.
The fight against cancer is one of the most important medical initiatives of our time, and almost weekly, it seems, some new therapy or freshly created medication is proposed as a possible weapon in…
The indirect financial costs of the nation's opioid crisis total a staggering $130 billion over the past 20 years, according to new estimates from a team of researchers at Penn State University.
Merck released better than expected second-quarter financial results before the markets opened on Tuesday.
Pfizer and Merck are each scheduled to release their second-quarter financial results early Tuesday. These are just a couple of the Dow Jones industrials that are reporting this week, but they make up half…
We’ve long known that fruit and vegetables are good for us in many ways, and the U.S. Dietary Guidelines for Americans recommends that they constitute half of what’s on our plates at every meal.…